🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carly Pilcher

The Ohio State University

ORCID: 0000-0003-2696-6746
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer”.

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer

Investigational New Drugs(2025)10.1007/s10637-025-01591-y
N/A
0.165DataRank · unranked
2 citations

Ruohan Wu, Lai Wei, Mikhail M. Dikov, Shankar Suman, Po‐Lan Su +17 more

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1552
N/A
0DataRank · unranked
36 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090.v1
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more